Organisms | Evidence |
---|---|
Mus musculus (house mouse) | |
Rattus norvegicus (Norway rat) | |
Homo sapiens (human) | |
Drosophila melanogaster (fruit fly) | |
Streptococcus pneumoniae |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
B4GALT2 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
B4GALT1 | UDP-Gal |
|
R |
|
R | |
B3GALT5 | UDP-Gal |
|
R |
|
R |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
B4GALT3 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
B4GALT4 | UDP-Gal |
|
[beta]-1-Benzl |
|
[beta]-1-Benzl | |
B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
B4GALT4 | UDP-Gal |
|
[beta]-1-4-methyl-umbelliferyl |
|
[beta]-1-4-methyl-umbelliferyl |
Pathway Name | Organism |
---|---|
E.coli O137 | Escherichia coli |
E.coli O138 | Escherichia coli |
E.coli O141 | Escherichia coli |
E.coli O142 | Escherichia coli |
E.coli O143 | Escherichia coli |
E.coli O145 | Escherichia coli |
E.coli O149 | Escherichia coli |
E.coli O15 | Escherichia coli |
E.coli O150 | Escherichia coli |
E.coli O151 | Escherichia coli |
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
PubMed ID | Title | First Author | Publication Date | Source |
---|---|---|---|---|
37901798 | A potent and broad‐spectrum neutralizing nanobody for SARS‐CoV‐2 viruses, including all major Omicron strains | Yao H | 2023 Oct 26 |
|
37872202 | Structure-function analyses reveal key molecular determinants of HIV-1 CRF01_AE resistance to the entry inhibitor temsavir | Prévost J | 2023 Oct 23 |
|
37867237 | Targeting USP8 Inhibits O-GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT | Tang J | 2023 Oct 22 |
|
37856504 | Exploiting O-GlcNAc transferase promiscuity to dissect site-specific O-GlcNAcylation | Mitchell CW | 2023 Oct 19 |
|
37851455 | High-Level Production of Lacto-N-neotetraose in Escherichia coli by Stepwise Optimization of the Biosynthetic Pathway | Zhang M | 2023 Oct 18 |
|
37848414 | O-GlcNAcylation regulates neurofilament-light assembly and function and is perturbed by Charcot-Marie-Tooth disease mutations | Huynh DT | 2023 Oct 17 |
|
37842859 | Nutritional and metabolic control of germ cell fate through O‐GlcNAc regulation | Hayashi Y | 2023 Oct 16 |
|
37669729 | 3D printed pH-responsive tablets containing N-acetylglucosamine-loaded methylcellulose hydrogel for colon drug delivery applications | Asadi M | 2023 Oct 15 |
|
37544422 | A novel Toll-like receptor 7/8–specific antagonist E6742 ameliorates clinically relevant disease parameters in murine models of lupus | Ishizaka ST | 2023 Oct 15 |
|
37838775 | EOGT enables residual Notch signaling in mouse intestinal cells lacking POFUT1 | Nauman M | 2023 Oct 14 |
|
Title | Authors | Source | Publication Date | PubMed ID |
---|---|---|---|---|
Dynamic glycosylation of the transcription factor CREB: a potential role in gene regulation. |
|
J Am Chem Soc | 2003 Jun 4 | 12769553 |
Effect of okadaic acid on O-linked N-acetylglucosamine levels in a neuroblastoma cell line. |
|
Biochim Biophys Acta | 1999 Oct 18 | 10572927 |
Regulation of a cytosolic and nuclear O-GlcNAc transferase. Role of the tetratricopeptide repeats. |
|
J Biol Chem | 1999 Nov 5 | 10542233 |
An N-terminal region of Sp1 targets its proteasome-dependent degradation in vitro. |
|
J Biol Chem | 1999 May 21 | 10329728 |
Vertebrate lens alpha-crystallins are modified by O-linked N-acetylglucosamine. |
|
J Biol Chem | 1992 Jan 5 | 1730617 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025